Status:
COMPLETED
Efficacy of Sublingual Immunotherapy in Polysensitized Allergic Rhinitis Patients
Lead Sponsor:
Seoul National University Hospital
Conditions:
Allergic Rhinitis
Eligibility:
All Genders
4-53 years
Phase:
NA
Brief Summary
Recently, interest has increased in sublingual immunotherapy (SLIT) for treating allergic rhinitis. It is often suggested that polysensitized patients might not benefit from specific immunotherapy as ...
Eligibility Criteria
Inclusion
- Patients who had sneezing, itching, rhinorrhea, and nasal congestion with or without eye symptoms
- patients who were sensitized to Dermatophagoides pteronyssinus (Dp) or D. farinae (Df), as confirmed by skin prick testing (A/H ratio ≥ 1) or MAST
Exclusion
- Patients who had immunotherapy in the preceding 3 years
- Patients who had systemic immunological disorders
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT01247259
Start Date
November 1 2007
End Date
October 1 2010
Last Update
November 24 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Otorhinolaryngology, Seoul National University Hospital
Seoul, South Korea, 110-744